Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I5K2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 32 | 36 | PF00656 | 0.569 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.504 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.486 |
CLV_PCSK_FUR_1 | 25 | 29 | PF00082 | 0.674 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.555 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.601 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.555 |
CLV_PCSK_PC1ET2_1 | 27 | 29 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.472 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.386 |
DEG_SCF_SKP2-CKS1_1 | 58 | 65 | PF00560 | 0.405 |
DOC_CKS1_1 | 44 | 49 | PF01111 | 0.623 |
DOC_USP7_UBL2_3 | 103 | 107 | PF12436 | 0.423 |
DOC_USP7_UBL2_3 | 18 | 22 | PF12436 | 0.558 |
DOC_USP7_UBL2_3 | 90 | 94 | PF12436 | 0.472 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.684 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.415 |
LIG_14-3-3_CanoR_1 | 25 | 34 | PF00244 | 0.662 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.516 |
LIG_LIR_Gen_1 | 81 | 87 | PF02991 | 0.441 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.440 |
LIG_NRP_CendR_1 | 112 | 115 | PF00754 | 0.495 |
LIG_PCNA_yPIPBox_3 | 37 | 48 | PF02747 | 0.483 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.460 |
LIG_SH2_PTP2 | 83 | 86 | PF00017 | 0.435 |
LIG_SH2_SRC | 83 | 86 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 2 | 5 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.435 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.619 |
LIG_SUMO_SIM_anti_2 | 72 | 78 | PF11976 | 0.424 |
MOD_CDK_SPK_2 | 43 | 48 | PF00069 | 0.567 |
MOD_CDK_SPxK_1 | 59 | 65 | PF00069 | 0.398 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.574 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.570 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.576 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.609 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.523 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.614 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.466 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.558 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.656 |
MOD_PK_1 | 94 | 100 | PF00069 | 0.510 |
MOD_PKA_1 | 18 | 24 | PF00069 | 0.614 |
MOD_PKA_1 | 27 | 33 | PF00069 | 0.545 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.614 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.545 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.649 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.682 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.411 |
MOD_SUMO_rev_2 | 85 | 92 | PF00179 | 0.468 |
MOD_SUMO_rev_2 | 97 | 105 | PF00179 | 0.439 |
TRG_DiLeu_BaEn_1 | 101 | 106 | PF01217 | 0.436 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.499 |
TRG_ENDOCYTIC_2 | 2 | 5 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.435 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P9Q9 | Leptomonas seymouri | 67% | 69% |
A0A3Q8IFM8 | Leishmania donovani | 98% | 70% |
A4HIB8 | Leishmania braziliensis | 78% | 100% |
E9B0U7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q7B9 | Leishmania major | 91% | 100% |